News

Filter

Current filters:

None

7926 to 7935 of 96191 results

Strong Ph III results for Lundbeck alcohol dependence drug Selincro

06-03-2012

Danish CNS drug specialist Lundbeck (LUN DC) announced positive results of a Phase III clinical program…

LundbeckNeurologicalPharmaceuticalResearchSelincro

Agenus expands deal with GlaxoSmithKline; Nuron in-licenses vaccines

06-03-2012

US biotech firm Agenus (Nasdaq: AGEN) says it has amended the QS-21 license and manufacturing agreement…

AgenusAkshaya BioBiotechnologyGlaxoSmithKlineLicensingNuron BiotechPharmaceuticalVaccines

New Zealand to fund new cancer drugs Tykerb and Votrient

05-03-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, says it is funding two new targeted cancer…

Asia-PacificGlaxoSmithKlineOncologyPharmaceuticalPricingRegulationTykerbVotrient

Senior appointments as Sanofi and Onyx

05-03-2012

French drug major Sanofi (Euronext: SAN) has named former Bayer executive Jean-Luc Lowinski as senior…

ManagementOnyx PharmaceuticalsPharmaceuticalSanofi

EMA updates market authorization holder requirements

05-03-2012

Pharmaceutical regulator the European Medicines Agency said yesterday that it has published an updated…

BiotechnologyEuropePharmaceuticalRegulation

Proximagen boasts strong cash balance, updates on R&D

05-03-2012

UK-based CNS and inflammatory diseases specialist Proximagen (AIM: PRX) has announced its unaudited preliminary…

FinancialPharmaceuticalProximagenResearch

SciClone drops oral mucositis candidate SCV-07

05-03-2012

USA-based SciClone Pharmaceuticals (Nasdaq: SCLN) said on Friday that results from a pre-planned interim…

Asia-PacificMarkets & MarketingOncologyPharmaceuticalResearchSciClone Pharma

7926 to 7935 of 96191 results

Back to top